| DIRECT COMPETITOR COMPARISON | |
| BMY | MRK | NVS | PFE | Industry | | Market Cap: | 49.62B | 76.82B | 124.35B | 149.53B | 128.76M | | Employees: | 35,000 | 55,200 | 99,000 | 81,800 | 181 | | Qtrly Rev Growth (yoy): | 4.40% | 1.80% | 2.40% | -2.90% | 14.60% | | Revenue (ttm): | 21.14B | 23.37B | 42.31B | 45.82B | 31.21M | | Gross Margin (ttm): | 72.39% | 76.36% | 72.61% | 86.61% | 72.39% | | EBITDA (ttm): | 6.32B | 7.81B | 11.24B | 21.31B | -1.66M | | Oper Margins (ttm): | 26.65% | 26.63% | 21.50% | 37.42% | -18.10% | | Net Income (ttm): | 3.79B | 8.05B | 7.59B | 8.09B | N/A | | EPS (ttm): | 1.933 | 3.808 | 3.34 | 1.204 | N/A | | P/E (ttm): | 12.96 | 9.56 | 16.39 | 15.39 | 13.61 | | PEG (5 yr expected): | 2.06 | 2.11 | 2.75 | 5.91 | 1.99 | | P/S (ttm): | 2.35 | 3.29 | 2.94 | 3.26 | 3.29 |
|
| MRK = Merck & Co. Inc. | | NVS = Novartis AG | | PFE = Pfizer Inc. | | Industry = Drug Manufacturers - Major | |
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.25 | 0.00% | 56.93B | 12.27 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 46.79 | 0.00% | 13.53B | 15.66 | | Genzyme Corp. | GENZ | 50.24 | 0.00% | 13.33B | 28.64 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 47.01 | 0.00% | 42.31B | 18.18 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 49.83 | 0.00% | 8.89B | 1016.94 | | Teva Pharmaceutical Industries Limited | TEVA | 53.43 | 0.00% | 47.07B | 48.88 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 35.55 | 0.00% | 3.77B | 18.32 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 12.06 | 0.00% | 2.99B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 17.98 | 0.00% | 5.49B | 110.31 | | Pfizer Inc. | PFE | 18.53 | 0.00% | 149.53B | 15.39 | | Johnson & Johnson | JNJ | 62.69 | 0.00% | 172.97B | 13.69 | | GlaxoSmithKline plc | GSK | 42.14 | 0.00% | 106.82B | 13.09 | | Sanofi-Aventis | SNY | 38.62 | 0.00% | 100.84B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 54.75 | 0.00% | 124.35B | 16.39 | | RHHBY.PK | 40.96 | 0.00% | N/A | N/A | | AstraZeneca plc | AZN | 45.40 | 0.00% | 65.83B | 9.12 | | Abbott Laboratories | ABT | 53.13 | 0.00% | 82.18B | 14.39 | | Bristol-Myers Squibb Co. | BMY | 25.05 | 0.00% | 49.62B | 12.96 |
|
| NEWS ON DIRECT COMPETITORS | |
|
|
|